RARE ALERT: Motif Bio said to have kicked off $3 million equity fundraising - sources

Monday, 25 March 2019, 6:38 am

Motif Bio, a clinic stage biopharmaceutical company, is tapping investors for up to $3 million.

People claiming to be familiar with the situation said Motif Bio is looking to raise the fresh capital at a 25pc discount to last Friday's opening price.

The proceeds from the equtiy fundraising will be used as working capital, said people claiming to be familiar with the matter.

Motif Bio, whose shares are also listed on the Nasdaq, is focused on developing novel antibiotics designed to be effective against serious and life-threatening infections...

Register

Register for free to see rest of this article and all public articles from Betaville

Login / Register
Tags: Motif Bio

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Post Comment